TA
Tamarack Advisers Portfolio holdings
AUM
$2.12M
This Quarter Return
+5.39%
1 Year Return
-56.28%
3 Year Return
-45.76%
5 Year Return
+44.93%
10 Year Return
–
AUM
$525M
AUM Growth
–
Cap. Flow
+$525M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
65.95%
Holding
30
New
26
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
PDCO
Patterson Companies, Inc.
PDCO
|
$47.5M |
| 2 |
Quest Diagnostics
DGX
|
$46.2M |
| 3 |
ELGX
Endologix Inc
ELGX
|
$44.3M |
| 4 |
NXTM
NxStage Medical Inc.
NXTM
|
$42.2M |
| 5 |
Medtronic
MDT
|
$38.5M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 85.38% |
| 2 | Technology | 3.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
PDCO
1
DELISTED
Patterson Companies, Inc.
PDCO
| $47.5M | 6.25% |
+1,050,000
| New | +$47.5M |
|
|
2
Quest Diagnostics
DGX
$20.3B
| $46.2M | 6.09% |
+650,000
| New | +$46.2M |
|
|
ELGX
3
DELISTED
Endologix Inc
ELGX
| $44.3M | 5.83% |
+4,475,000
| New | +$44.3M |
|
|
NXTM
4
DELISTED
NxStage Medical Inc.
NXTM
| $42.2M | 5.55% |
+1,925,000
| New | +$42.2M |
|
|
5
Medtronic
MDT
$119B
| $38.5M | 5.06% |
+500,000
| New | +$38.5M |
|
6
Integer Holdings
ITGR
$3.78B
| $35.4M | 4.66% |
+675,000
| New | +$35.4M |
|
|
MDRX
7
DELISTED
Veradigm Inc. Common Stock
MDRX
| $28.5M | 3.74% |
+1,850,000
| New | +$28.5M |
|
8
Alkermes
ALKS
$4.78B
| $23.8M | 3.13% |
+300,000
| New | +$23.8M |
|
|
SPNC
9
DELISTED
Spectranetics Corp
SPNC
| $20.3M | 2.68% |
+1,350,000
| New | +$20.3M |
|
|
LMNX
10
DELISTED
Luminex Corp
LMNX
| $19.8M | 2.6% |
+925,000
| New | +$19.8M |
|
|
IMPR
11
DELISTED
IMPRIVATA, INC COM
IMPR
| $19.7M | 2.6% |
+1,746,000
| New | +$19.7M |
|
12
Becton Dickinson
BDX
$55.3B
| $19.3M | 2.54% |
+125,000
| New | +$19.3M |
|
13
Bio-Rad Laboratories Class A
BIO
$8.06B
| $17.3M | 2.28% |
+125,000
| New | +$17.3M |
|
14
Perrigo
PRGO
$3.27B
| $17.1M | 2.25% |
+118,000
| New | +$17.1M |
|
15
Steris
STE
$24.1B
| $15.8M | 2.07% |
+209,169
| New | +$15.8M |
|
16
AtriCure
ATRC
$1.84B
| $15.7M | 2.07% |
+700,000
| New | +$15.7M |
|
17
AstraZeneca
AZN
$248B
| $13.6M | 1.79% |
+400,000
| New | +$13.6M |
|
|
CORI
18
DELISTED
Corium International, Inc.
CORI
| $11.2M | 1.48% |
+1,385,000
| New | +$11.2M |
|
|
AMRN
19
Amarin Corp
AMRN
$311M
| $10.4M | 1.37% |
+5,500,000
| New | +$10.4M |
|
|
ALR
20
DELISTED
Alere Inc
ALR
| $8.8M | 1.16% |
+225,000
| New | +$8.8M |
|
|
ESRX
21
DELISTED
Express Scripts Holding Company
ESRX
| $8.74M | 1.15% |
+100,000
| New | +$8.74M |
|
|
SGNT
22
DELISTED
SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT
| $7.16M | 0.94% |
+450,000
| New | +$7.16M |
|
|
XENT
23
DELISTED
Intersect ENT, Inc
XENT
| $5.61M | 0.74% |
+249,296
| New | +$5.61M |
|
|
SRGA
24
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
| $4.96M | 0.65% |
+1,250,000
| New | +$4.96M |
|
25
Glaukos
GKOS
$5.5B
| $1.89M | 0.25% |
+76,502
| New | +$1.89M |
|